Bcl-2 down modulation in WEHI-3B/CTRES cells resistant to Cholera Toxin (CT)-induced apoptosis

Cell Research

Volumn 16, Issue 3, 2006, Pages 306-312

  Pessina, Augusto ^a   Croera, Cristina ^b   Savalli, Nicoletta ^c   Bonomi, Arianna ^a   Cavicchini, Loredana ^a   Turlizzi, Elisa ^a   Guizzardi, Fabiana ^a   Guido, Lucia ^a   Daprai, Laura ^a   Neri, Maria Grazia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b JOINT RESEARCH CENTRE   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Bcl 2; Cholera toxin; Ciprofloxacin; PKA; Resistance

Indexed keywords

CHOLERA TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CLONE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; GENETICS; METABOLISM; MOUSE; MYELOID LEUKEMIA; PROTO ONCOGENE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLERA TOXIN; CLONE CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; GENES, BCL-2; LEUKEMIA, MYELOID; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33645088932     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7310038     Document Type: Article

References (43)

1. Fishman P. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol 1982; 69:85-97.
2. Griffiths SL, Finkelstein RA, Critchley DR. Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders. Biochem J 1986; 238:313-322.
3. Holmgren J, Lindblad H, Fredman P, Svennerholm L, Myrvold A. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 1985; 89:27-35.
4. Nakamura K, Suzuki M, Inagaki F, Yamakawa T, Suzuki A. A new ganglioside showing cholera genoid-binding activity in mouse spleen. J Biochem 1987; 101:825-835.
5. Pacuszka T, Bradley RM, Fishman PH. Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. Biochemistry 1991; 30:2563-2570.
6. Smets LA, Van Roy H. Mitogenic and anti-mitogenic effect of cholera toxin-mediated cyclic AMP levels in 3T3 cells. J Cell Physiol 1987; 133:395-399.
7. Rozengurt E, Legg A, Strang G, Courtenay-Luck N. Cyclic AMP: a mitogenic signal for Swiss 3T3 cells. Proc Natl Acad Sci U S A 1981; 78:4392-4396.
8. Enomoto K, Gill DM. Cholera toxin activation of adenylatecyclase. Biol Chem 1980; 255:1252-1258.
9. Anderson DL, Tsoukas CD. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J Immunol 1989; 43:3642-3647.
10. Chang FH, Bourne HR. Cholera toxin induces cAMP-independent degradation of Gs. J Biol Chem 1989; 264:5352-5357.
11. Francis ML, Okazaki I, Moss J, et al. cAMP-independent effects of cholera toxin on B cell activation. J Immunol 1995; 154:4956-4964.
12. Gouy H, Cefai D, Christensen SB, Debre P, Bismuth G. Cyclic AMP and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. J Immunol 1991; 147:757-7566.
13. Viallet J, Sharoni Y, Fricht H, et al. EA. Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small cells lung cancer. J Clin Invest 1990; 86:1904-1912.
14. Pessina A, Mineo E, Masserini M, Neri MG, Cocuzza CE. Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit. Biochem Biophys Acta 1989; 1013:206-211.
15. Giuliani A, Calappi E, Mineo E, et al. The different inhibiting effect of Cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity. Mol Cell Biochem 1995; 152:103-112.
16. Pessina A, Mineo E, Neri MG, et al. SR-4987 and L1210 cell lines two models in which Cholera Toxin susceptibility does not correlate with cAMP accumulation and ganglioside content. Cell Mol Biol 1998; 44:933-940.
17. Pessina A, Giuliani A, Croera C, et al. Selection of a WEHI-3B leukaemia cell subclone resistant to inhibition by cholera toxin. Mol Cell Biochem 2002; 2333:19-26.
18. Warner LN, Moore MAS, Metcalf D. A transplantable myelomonocytic leukemia in Balb/c mice: cytology, kariotipe and muramidase content. J Natl Cancer Inst 1969; 43:963-982.
19. +) leukaemia cells. Cancer J 1993; 6:291-297.
20. Pessina A, Gribaldo L, Mineo E, Neri MG. In vitro short-term and long-term cytotoxicity of fluoroquinolones on murine cell lines. Ind J Exp Biol 1994; 32:113-118.
21. McAteer JA, Devis J. Basic cell culture tecnique and the maintenance of cell lines. In: Davis JM, editor. Basic Cell Culture. Ed. Oxford University Press, Oxford. 1994; 93-148.
22. Donta ST. Comparison of the effects of cholera enterotoxin and ACTH on adrenal cells in tissue culture. Am J Phisiol 1974; 27:109-113.
23. Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65:55-63.
24. Hermann M, Lorenz HM, Voll R, et al. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucl Acids Res 1994; 22:5506.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
26. Laemli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1979; 24:145-149.
28. Yohe HC, Macala LJ, Giordano G, McHurray WJ. GM1b and GM1b-GalNAc: Major gangliosides of murine-derived macrophage-like WEHI-3 cells. Biochem Biophys Acta 1992; 1109:210-217.
29. 2+-mediated apoptosis through a protein kinase A-independent mechanism. Int Immunopharmacol 2002; 2:435-442.
30. Zhu Q, Zhang JW, Zhu HQ, et al. Synergic effects of arsenic trioxide and cAMP during acute promyeloytic leukemia cell maturation subtends a novel signalling cross-talk. Blood 2002; 99:1014-1022.
31. Muthing J, Schwinzer B, Peter-Katalinic J, Egge H, Mühlradt PF. Gangliosides of murine T lymphocyte subpopulations. Biochemistry 1989; 28:2923-2929.
32. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993; 262:1069-1072.
33. McKenzie FR, Pouyssegur J. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J Biol Chem 1996; 271:13476-13483.
34. Thomson S, Clayton AL, Hazzalin CA, et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. Embo J 1999; 18:4779-4793.
35. Chijiwa T, Mishima A, Hagiwara M, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265:5267-5272.
36. Leemhuis J, Boutillier S, Schmidt G, Meyer DK. The protein kinase A inhibitor H-89 acts on cell morphology by inhibiting Rho kinase. J Pharmacol Exp Ther 2002; 300:1000-1007.
37. Itano Y, Ito A, Uehara T, Nomura Y. Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectably. J Neurochem 1996; 67:131-137.
38. Yan L, Herrmann V, Hofer JK, Insel PA. beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279:C1665-1674.
39. Zhang L, Insel PA. Bcl-2 protects lymphoma cells from apoptosis but not growth arrest promoted by cAMP and dexamethasone. Am J Physiol Cell Physiol 2001; 281:C1642-1647.
40. Kim SN, Kim SG, Park JH, et al. Dual anticancer activity of 8-Cl-cAMP: inhibition of cell proliferation and induction of apoptotic cell death. Biochem Biophys Res Commun 2000; 273:404-410.
41. Belka C, Budach W. Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol 2002; 78:643-658.
42. Del Bufalo D, Biroccio A, Trisciuoglio D, et al. Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used. Eur J Cancer 2002; 38:2455-262.
43. Furukawa Y, Iwase S, Kikuchi J, et al. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation. J Biol Chem 2000; 275:21661-21667.